AnalystsJoel BeattyJoel Beatty's Stock Forecasts
AnalystsJoel Beatty
Analyst Ranking
Top 23%
#796 out of 3582 analysts
Average Return
+6.46%
Win Rate
41%19 out of 46
Risk vs Reward
Poor
Good
Joel Beatty's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
CymaBay Therapeutics IncCBAY | +258.57% | $1.40 | $5.02 | 2020-03-19 - 2021-03-19 | Strong Buy |
Esperion Therapeutics IncESPR | +197.78% | $26.17 | $77.93 | 2017-02-27 - 2018-01-22 | Strong Buy |
Arena Pharmaceuticals IncARNA | +173.80% | $15.23 | $41.70 | 2017-06-26 - 2018-06-27 | Strong Buy |
Ngm Biopharmaceuticals IncNGM | +120.11% | $13.08 | $28.79 | 2020-03-26 - 2021-03-26 | Strong Buy |
Arena Pharmaceuticals IncARNA | +74.76% | $25.36 | $44.32 | 2017-07-11 - 2018-07-12 | Strong Buy |
Joel Beatty's Stock Coverage
| Name / Ticker | # of Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vir Biotechnology IncVIR | 1 | Sell | $36.00 | +9.49% | Downgrades | a month ago |
Cardiff Oncology IncCRDF | 1 | Buy | $19.00 | +424.86% | Initiates Coverage On | 2 months ago |
Geron CorpGERN | 1 | Buy | $4.00 | +260.36% | Initiates Coverage On | 3 months ago |
BeyondSpring IncBYSI | 1 | Buy | $50.00 | +1,419.76% | Initiates Coverage On | 5 months ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Sell | N/A | N/A | Downgrades | 5 months ago |
Blueprint Medicines CorpBPMC | 1 | Buy | $123.00 | +70.17% | Maintains | 7 months ago |
Argenx SeARGX | 1 | Buy | $333.00 | +25.66% | Maintains | 8 months ago |
Pliant Therapeutics IncPLRX | 2 | Strong Buy | $52.00 | +356.54% | Initiates Coverage On | 10 months ago |
Alnylam Pharmaceuticals IncALNY | 2 | Hold | $175.00 | +28.18% | Downgrades | a year ago |
Vanda Pharmaceuticals IncVNDA | 4 | Hold | $14.00 | N/A | Downgrades | a year ago |
Sarepta Therapeutics IncSRPT | 2 | Hold | $108.00 | N/A | Downgrades | a year ago |
Ptc Therapeutics IncPTCT | 5 | Strong Buy | $85.00 | N/A | Upgrades | a year ago |
Eidos Therapeutics IncEIDX | 2 | Hold | $73.26 | N/A | Downgrades | a year ago |
Eloxx Pharmaceuticals IncELOX | 1 | Hold | $4.00 | N/A | Downgrades | 2 years ago |
Ayala Pharmaceuticals IncAYLA | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Tempest Therapeutics IncTPST | 2 | Strong Buy | $6.00 | N/A | Reinstates | 2 years ago |
Ionis Pharmaceuticals IncIONS | 2 | Strong Buy | $71.00 | N/A | Maintains | 2 years ago |
PhaseBio Pharmaceuticals IncPHAS | 1 | Strong Buy | $11.00 | N/A | Maintains | 2 years ago |
DBV Technologies SADBVT | 2 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Amarin Corp PlcAMRN | 3 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $28.00 | N/A | Maintains | 2 years ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
CymaBay Therapeutics IncCBAY | 1 | Strong Buy | $1.60 | N/A | Maintains | 2 years ago |
Esperion Therapeutics IncESPR | 5 | Strong Buy | N/A | N/A | Upgrades | 2 years ago |
Intercept Pharmaceuticals IncICPT | 5 | Strong Buy | N/A | N/A | Upgrades | 2 years ago |
Syndax Pharmaceuticals IncSNDX | 1 | Strong Buy | $12.00 | N/A | Maintains | 3 years ago |
Medicines CoMDCO | 3 | Strong Buy | $50.00 | N/A | Maintains | 3 years ago |
aTYR PHARMA INCLIFE | 1 | Hold | $0.75 | N/A | Upgrades | 3 years ago |
Astria Therapeutics IncATXS | 3 | Strong Buy | $1.50 | N/A | Maintains | 3 years ago |
Arena Pharmaceuticals IncARNA | 3 | Strong Buy | $55.00 | N/A | Maintains | 4 years ago |
Novavax IncNVAX | 3 | Hold | $2.75 | N/A | Maintains | 4 years ago |
Kura Oncology IncKURA | 1 | Strong Buy | $19.00 | N/A | Maintains | 4 years ago |
Dimension Therapeutics IncDMTX | 3 | Hold | N/A | N/A | Upgrades | 4 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.